Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.7.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Jun. 24, 2017
Jun. 25, 2016
Cash flows from operating activities:    
Income including noncontrolling interest $ 75,927 $ 51,478
Adjustments to reconcile net income to net cash used by operating activities:    
Depreciation and amortization 31,374 29,286
Amortization of deferred financing costs 1,021 1,164
Stock-based compensation 8,189 6,069
Excess tax benefits from stock-based awards (17,205) (4,726)
Deferred income taxes 10,420 12,305
Write-off of deferred financing costs 0 3,337
Loss on sale of property and equipment 96 788
Gain on sale of facility (2,050) (2,544)
Other 1,241 190
Change in assets and liabilities (excluding businesses acquired):    
Accounts receivable (74,234) (13,236)
Inventories (17,347) (5,928)
Prepaid expenses and other assets 11,774 6,493
Accounts payable 2,901 (8,027)
Accrued expenses 10,629 14,812
Other long-term obligations (88) (1,878)
Net cash provided by operating activities 42,648 89,583
Cash flows from investing activities:    
Additions to property and equipment (37,087) (19,486)
Payments to acquire companies, net of cash acquired (106,821) (68,901)
Proceeds from the sale of business, facility and other assets 8,301 3,899
Change in restricted cash (89) 1,129
Investment in equity method investee (11,495) 0
Other investing activities (2,735) (550)
Net cash used in investing activities (149,926) (83,909)
Cash flows from financing activities:    
Repayments of long-term debt (456) (400,230)
Proceeds from issuance of long-term debt 0 400,000
Borrowings under revolving line of credit 456,000 419,000
Repayments under revolving line of credit (416,000) (419,000)
Proceeds from issuance of common stock 0 280
Repurchase of common stock, including shares surrendered for tax withholding (25,654) (9,429)
Payment of contingent consideration liability (1,222) 0
Distribution to noncontrolling interest (1,019) (592)
Payment of financing costs 0 (7,560)
Excess tax benefits from stock-based awards 17,205 4,726
Net cash provided (used) by financing activities 28,854 (12,805)
Effect of exchange rate changes on cash and cash equivalents (85) (453)
Net decrease in cash and cash equivalents (78,509) (7,584)
Cash and equivalents at beginning of period 92,982 47,584
Cash and equivalents at end of period 14,473 40,000
Supplemental information:    
Cash paid for interest $ 27,075 $ 32,440